korrents

korrents · piece

Hub-and-Spoke Biotechs: BridgeBio

Elliot Hershberg · 16 Feb 2025

The piece opens with

The biotech industry has not undergone the same exhaustive search for every commercializable opportunity that followed the internet's growth boom.

What we haven't seen is the same type of frantic hunt for every nugget of value that could be commercialized as a result of this enormous secular trend.

Read the piece on centuryofbio.com ↗

3 korrents from this piece ↓

Elliot Hershberg did not write this page.

Every claim below was made in this piece, quoted word for word and numbered in the order the piece makes them, so you can read it there rather than take our word for it. The sentence above each quote is our reading of the claim, not their wording. Each quote was checked against a stored copy of the page at build time; where the two differ, the quote is the fact.

  1. What we haven't seen is the same type of frantic hunt for every nugget of value that could be commercialized as a result of this enormous secular trend.
  2. The set of diseases for which we have a molecular explanation-which resembles the equivalent of the Craigslist homepage for this analogy-has grown far faster than the corresponding set of new drugs to treat them.
  3. I think this partially explains some of the discontent in the scientific community about the Human Genome Project. After billions of dollars that could have been spent in other places, the result is less transformative than initially advertised.

Keep reading

The other pieces are the ones whose claims are worded most like this one's. That measures language, not agreement: they may argue the opposite.